EUVIMEDEUVIMED entdecken
Crossref

L26/O-284 How a specific gene mutation, detected in the seminal fluid, affects testicular spermatogenesis

S. Cheung, L. Ng, P. Xie, Z. Rosenwaks, G.D. Palermo

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Cheung und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can epigenomic profiling of seminal fluid at initial semen analysis predict residual spermatogenesis and successful testicular sperm retrieval in men with nonobstructive azoospermia (NOA)? Summary answer We confirmed that a novel gene mutation impairs meiotic completion by inducing apoptosis in the seminiferous tubule and is responsible for failed testicular sperm retrieval. What is known already There are no reliable predictors for a successful testicular biopsy; thus, there is no way to spare patients from unnecessary surgical risk. In a preliminary seminal fluid epigenomic assessment in NOA men, NEU1 emerged as consistently dysfunctional in those with unsuccessful micro-TESE outcomes. NEU1’s primary function is lysosomal desialylation, and although it has been implicated in the regulation of sperm fertilization capacity and motility, its mechanistic impact on spermatogenesis remains unknown. In this study, we explore how the disruption of this gene affects sperm production, aiming to predict residual spermatogenesis and improve preoperative prognosis in NOA patients. Study design, size, duration Over 2 years, 45 consenting NOA men undergoing micro-TESE (IRB#1006101085) were grouped by sperm retrieval outcomes. Following RNAseq and DNAseq, variant filtering identified novel NEU1 mutations in failed micro-TESE patients. To test causality, an experimental model was devised using mutant mouse embryonic stem cells (mESCs) cultured alongside a wildtype control in a novel three-dimensional in vitro spermatogenesis model. Germ cell differentiation marker expression, ploidy, and DNA fragmentation were compared between mutant and wildtype mESCs. Participants/materials, setting, methods Seminal fluid samples from NOA men were profiled by RNAseq and DNAseq. CRISPR-Cas9-mediated homology-directed repair was performed to edit the genome of C57BL/6-derived mESCs. Mutant and wildtype mESCs were embedded in an alginate-based three-dimensional niche and cultured for 29 days in BMP4, LIF, SCF, and EGF-supplemented differentiation media. To monitor the effect on spermatogenesis, stage-specific markers were assessed weekly by immunofluorescence. DNA fragmentation and ploidy were assessed by TUNEL and fluorescence in situ hybridization, respectively. Main results and the role of chance A total of 45 NOA men (paternal age: 36.8±5 years) were included in this study. Transcriptomic analyses on seminal fluid identified NEU1 as exclusively and consistently underexpressed in 27 patients with failed micro-TESE outcomes (-Sperm) yet overexpressed in the successful micro-TESE cohort (+Sperm; n = 18). Genetic assessment revealed a novel NEU1 frameshift mutation (c.48dup), corroborating the transcriptomic findings. To test causality of this mutation, we reproduced spermatogenesis in vitro in an animal model. Wildtype mESCs exhibited normal germ cell differentiation with successful completion of meiosis, confirmed by spermatid-stage marker expression (Acrosin; 6.7%) and ploidy assessment (80.6% haploid). DNA fragmentation was also consistently low throughout differentiation (21.8±6%). Next, we performed a functional assay by fusing the mESC-derived germ cells into mouse oocytes, which generated a 55.6% embryo developmental rate. The CRISPR-edited mESCs underwent antibiotic selection to isolate cells carrying the NEU1 frameshift, which was subsequently validated by DNA sequencing. Assessment of germ cell progression of the NEU1-mutant mESCs demonstrated negligible spermatogonia-stage marker expression (DAZL; 2.8%), followed by complete differentiation arrest at the primary spermatocyte stage. Moreover, DNA fragmentation was remarkably elevated, at 64±19% (P<0.005), and no haploid cells were identified. Finally, the injection of NEU1-mutant cells did not yield any fertilization. Limitations, reasons for caution These results provide preliminary mechanistic evidence that this novel NEU1 mutation disrupts spermatogenesis by inducing germ cell apoptosis and meiotic arrest. Although this study identifies an additional function of this particular gene, the effects should be confirmed in a larger cohort and by independent investigators. Wider implications of the findings Our findings suggest that NEU1, beyond its established functions, appears to be a critical regulator of germ cell survival and consequently meiosis, offering a mechanistic explanation for the failed progression of spermatogenesis in the seminiferous tubule. This may serve as a noninvasive bioassay to predict successful micro-TESE in NOA men. Trial registration number No

Zitieren

APA

Cheung, S., Ng, L., Xie, P., Rosenwaks, Z., & Palermo, G. (2026). L26/O-284 How a specific gene mutation, detected in the seminal fluid, affects testicular spermatogenesis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.282

Vancouver

Cheung S, Ng L, Xie P, Rosenwaks Z, Palermo G. L26/O-284 How a specific gene mutation, detected in the seminal fluid, affects testicular spermatogenesis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.282

BibTeX
@article{Cheung2026,
  author = {Cheung, S. and Ng, L. and Xie, P. and Rosenwaks, Z. and Palermo, G.D.},
  title = {L26/O-284 How a specific gene mutation, detected in the seminal fluid, affects testicular spermatogenesis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.282}
}
Kostenlos starten →